[1]
A. Ahmed, A. and Azzam 2025. Comparative study of Olopatadine 0.1% and Lodoxamide 0.1% in treatment of seasonal allergic conjunctivitis. Annals of the College of Medicine, Mosul. 36, 1 (Jun. 2025), 138–145. DOI:https://doi.org/10.33899/mmed.2010.8919.